Increased inflammation in mice deficient for the chemokine decoy receptor D6

Chemokines are chemotactic cytokines with a key role in the control of cell trafficking and positioning under homeostatic and inflammatory conditions. D6 is a promiscuous 7‐transmembrane‐domain receptor expressed on lymphatic vessels which recognizes most inflammatory, but not homeostatic, CC chemokines. In vitro experiments demonstrated that D6 is unable to signal after ligand engagement, and it is structurally adapted to sustain rapid and efficient ligand internalization and degradation. These unique functional properties lead to the hypothesis that D6 may be involved in the control of inflammation by acting as a decoy and scavenger receptor for inflammatory chemokines. Consistent with this hypothesis, here we report that D6–/– mice showed an anticipated and exacerbated inflammatory response in a model of skin inflammation. Moreover, the absence of D6 resulted in increase cellularity and inflammatory‐chemokine levels in draining lymph nodes. Thus, D6 is a decoy receptor structurally adapted and strategically located to tune tissue inflammation and control transfer of inflammatory chemokines to draining lymph nodes.

[1]  D. Steiner,et al.  Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.

[2]  M. Gobbi,et al.  Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor1 , 2004, The Journal of Immunology.

[3]  Zhaohua Lu,et al.  The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.

[4]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[5]  R. Nibbs,et al.  The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. , 2004, Molecular biology of the cell.

[6]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[7]  M. Gobbi,et al.  Cutting Edge: Scavenging of Inflammatory CC Chemokines by the Promiscuous Putatively Silent Chemokine Receptor D6 1 , 2003, The Journal of Immunology.

[8]  Stanislav Y. Shvartsman,et al.  Argos inhibits epidermal growth factor receptor signalling by ligand sequestration , 2004, Nature.

[9]  M Locati,et al.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.

[10]  J. Sedgwick,et al.  Tumor Necrosis Factor–dependent Segmental Control of MIG Expression by High Endothelial Venules in Inflamed Lymph Nodes Regulates Monocyte Recruitment , 2001, The Journal of experimental medicine.

[11]  P. Murphy The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[12]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[13]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[14]  R. Nibbs,et al.  Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5. , 1997, The Journal of biological chemistry.

[15]  A. Proudfoot Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[16]  R. Nibbs,et al.  Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.

[17]  J. Johnston,et al.  Chemokines and serpentines: the molecular biology of chemokine receptors , 1993, Journal of leukocyte biology.

[18]  Alberto Mantovani,et al.  β-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6* , 2004, Journal of Biological Chemistry.

[19]  D. Kerjaschki,et al.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. , 2001, The American journal of pathology.